Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Inventory (2016 - 2025)

Apyx Medical (APYX) has disclosed Change in Inventory for 15 consecutive years, with -$511000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Inventory rose 62.45% year-over-year to -$511000.0, compared with a TTM value of $1.1 million through Dec 2025, up 147.46%, and an annual FY2025 reading of $1.1 million, up 147.46% over the prior year.
  • Change in Inventory was -$511000.0 for Q4 2025 at Apyx Medical, down from $865000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.8 million in Q2 2022 and bottomed at -$1.4 million in Q4 2024.
  • Average Change in Inventory over 5 years is $288950.0, with a median of $272000.0 recorded in 2023.
  • The sharpest move saw Change in Inventory soared 436.99% in 2021, then plummeted 917.31% in 2023.
  • Year by year, Change in Inventory stood at $877000.0 in 2021, then plummeted by 111.86% to -$104000.0 in 2022, then tumbled by 917.31% to -$1.1 million in 2023, then fell by 28.64% to -$1.4 million in 2024, then skyrocketed by 62.45% to -$511000.0 in 2025.
  • Business Quant data shows Change in Inventory for APYX at -$511000.0 in Q4 2025, $865000.0 in Q3 2025, and $521000.0 in Q2 2025.